Agnès Burel

Agnès Burel

Auto-generated profile, based on publicly available information

Agnès Burel

Univ Rennes, CNRS, Inserm, MRIC-TEM platform, Rennes, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2018 in Nanotoxicology
Verified
Journal Article
Open access
HSHolger Sieg
Holger Sieg
CBCaroline Braeuning
Caroline Braeuning
BKBirgitta Maria Kunz
Birgitta Maria Kunz
HDHannes Daher
Hannes Daher
CKClaudia Kästner
Claudia Kästner
ALAlfonso Lampen
Alfonso Lampen
Aluminum (Al) is one of the most common elements in the earth crust and increasingly used in food, consumer products and packaging. Its hazard potential for humans is still not completely understood. Besides the metallic form, Al also exists as mineral, including the insoluble oxide, and in soluble ionic forms. Representatives of these three species, namely a metallic and an oxidic species of Al-containing nanoparticles and soluble aluminum chloride, were applied to human intestinal cell lines as models for the intestinal barrier. We characterized physicochemical particle parameters, protein corona composition, ion release and cellular uptake. Different in vitro assays were performed to determine potential effects and molecular modes of action related to the individual chemical species. For a deeper insight into signaling processes, microarray transcriptome analyses followed by bioinformatic data analysis were employed. The particulate Al species showed different solubility in biological media. Metallic Al nanoparticles released more ions than Al2O3 nanoparticles, while AlCl3 showed a mixture of dissolved and agglomerated particulate entities in biological media. The protein corona composition differed between both nanoparticle species. Cellular uptake, investigated in transwell experiments, occurred predominantly in particulate form, whereas ionic Al was not taken up by intestinal cell lines. Transcellular transport was not observed. None of the Al species showed cytotoxic effects up to 200 µg Al/mL. The transcriptome analysis indicated mainly effects on oxidative stress pathways, xenobiotic metabolism and metal homeostasis. We have shown for the first time that intestinal cellular uptake of Al occurs preferably in the particle form, while toxicological effects appear to be ion-related.

1 February 2022 in Toxicology in Vitro
Verified
Journal Article
Closed access
PJPégah Jalili
Pégah Jalili
SHSylvie Huet
Sylvie Huet
ABAgnès Burel
Agnès Burel
BKBenjamin Krause
Benjamin Krause
CFCaroline Fontana
Caroline Fontana
VFValerie Fessard
Valerie Fessard

17 November 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YDYoann Daniel
Yoann Daniel
CRClaudine Rauch
Claudine Rauch
LMLucille Moutaux
Lucille Moutaux
LDLise Desquilles
Lise Desquilles
TCTifenn Le Charpentier
Tifenn Le Charpentier
ACAnne Corlu
Anne Corlu
Human hepatocellular carcinomas (HCCs) with cancer stem cell (CSC) features are a subclass of therapeutically challenging cancers. We recently showed that retrodifferentiation of hepatic cancer cells into CSC-like cells leads to metabolic reprogramming and chemoresistance. The molecular mechanisms whereby differentiated cancer cells switch towards a CSC phenotype are poorly understood. By studying metabolic reprogramming associated with HCC cell plasticity, we identified an unsuspected role of peroxisome proliferator-activated receptor (PPAR)γ in hepatic CSC phenotype acquisition. Gene expression and metabolic analyses performed throughout the cell differentiation/retrodifferentiation process of human HepaRG and HBG-BC2 HCC cells show that metabolic reprogramming in hepatic CSCs is associated with a fragmented mitochondrial network, decreased respiration, de novo lipogenesis, and fatty acid oxidation, but increased glycolysis and lipid storage. Mitochondrial genes downregulated in HepaRG-CSCs are also downregulated in the STEM HCC subclass. While PPARα is the main isoform in differentiated hepatic cells, we find high PPARγ expression in hepatic CSCs. Accordingly, nuclear localization of PPARγ is detected in human HCC tumors, and PPARγ high /PPARα low expression is associated with the STEM HCC subclass and a poor outcome in human HCC cohorts. PPARγ silencing or/and inhibition of its target gene pyruvate dehydrogenase kinase 4 reactivates cell respiration, increases reactive oxygen species production and sensitizes hepatic CSCs to chemotherapy. Conversely, PPARα activation synergizes with chemotherapy to induce cell death. Targeting PPARγ, a key regulator of metabolic reprogramming and stemness in hepatic CSCs, or modulating the PPARγ/PPARα balance that finely tunes the differentiation/retrodifferentiation process in HCC deserves further investigation for anti-tumor therapy.

1 September 2020 in Systematic and Applied Microbiology
Verified
Journal Article
Closed access
CLCaroline Leyer
Caroline Leyer
MSMohamed Sassi
Mohamed Sassi
FGFrédéric Gourmelen
Frédéric Gourmelen
ABAgnès Burel
Agnès Burel
RBRacha Beyrouthy
Racha Beyrouthy
Vincent CattoirVincent Cattoir
Vincent Cattoir